Complete patient dosing for the fourth cohort of the AMT-130 study
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 10 Nov 2025
- Due
- 31 Dec 2025
- Delivered
- Q4 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Patient dosing is expected to complete before year-end 2025.”
What we found
Evidence strength A What the grades mean
The company confirmed in its SEC filings that dosing for the fourth cohort of the AMT-130 study was completed during the fourth quarter of 2025.
-
A uniQure N.V. 8-K filed 2026-03-02
“In the fourth quarter of 2025, dosing was completed in a fourth cohort of six patients receiving high-dose AMT-130” ✓ confirmed on the page
Market reaction: the shares moved -42.0% against the S&P 500 over the three sessions around the disclosure (27 Feb 2026 to 4 Mar 2026). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- AMT-130 fourth cohort dosing
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-QURE-001925 · Corrections policy